IMARC Group, a leading market research company, has recently released a report titled “Angioplasty Balloons Market Report by Product Type (Normal Balloons, Cutting Balloons, Drug Eluting Balloons, Scoring Balloons), Application (Coronary Angioplasty, Peripheral Angioplasty), Material (Nylon, Polyurethane, Silicone Urethane Co-Polymers, and Others), End-User (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2024-2032”. The study provides a detailed analysis of the industry, including the global angioplasty balloons market share, trends, size, and industry trends forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global angioplasty balloons market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 2.8% during 2024-2032.
Global Angioplasty Balloons Market Trends:
Increasing healthcare expenditure and improved access to advanced medical treatments in emerging economies are driving the angioplasty balloons market. Investments in healthcare infrastructure, including cardiovascular treatments, expand the availability and adoption of angioplasty balloons.
Additionally, rising healthcare awareness and preventive care initiatives positively impact market growth. Educational programs and campaigns emphasizing early diagnosis and treatment of cardiovascular conditions encourage proactive patient behavior, boosting the demand for angioplasty balloons.
Request to Get the Sample Report:
https://www.imarcgroup.com/angioplasty-balloons-market/requestsample
Factors Affecting the Growth of the Angioplasty Balloons Industry:
- Rising incidence of cardiovascular diseases (CVDs):
The growing prevalence of cardiovascular diseases is a key driver for the angioplasty balloons market. Conditions such as coronary artery disease (CAD), heart attacks, and peripheral artery disease (PAD) are becoming increasingly common worldwide, driven by factors like aging populations, sedentary lifestyles, poor diets, and rising obesity rates. Angioplasty balloons are essential for treating these conditions by widening narrowed or blocked blood vessels to restore normal blood flow. As the number of patients requiring such interventional treatments increases, so does the demand for angioplasty balloons. The substantial global burden of CVDs underscores the need for effective treatment options, including angioplasty.
- Technological advancements in balloon technology:
Innovations in angioplasty balloon technology are significantly impacting market growth. Developments such as drug-coated balloons (DCBs), which release medication directly to the arterial wall to prevent restenosis, have transformed the field. These advancements enhance the effectiveness of angioplasty procedures, improve patient outcomes, and minimize the risk of complications. New materials, such as more flexible and durable polymers, and improvements in balloon catheter design contribute to better performance and usability.
Additionally, the integration of advanced imaging technologies and guide systems with angioplasty balloons enables more precise interventions, driving market growth by ensuring healthcare providers have access to the latest tools.
- Increasing adoption of minimally invasive procedures:
The shift towards minimally invasive cardiovascular interventions has greatly influenced the angioplasty balloons market. Minimally invasive techniques, including angioplasty, are favored over traditional open-heart surgeries due to their benefits such as shorter recovery times, reduced hospital stays, and fewer complications. As both patients and healthcare providers recognize these advantages, the demand for angioplasty balloons grows. This trend reflects broader healthcare shifts towards enhancing patient comfort and outcomes, driven by advancements in medical technology, increased awareness of patient-centered care, and a focus on optimizing clinical results. The continued emphasis on minimally invasive treatments is expected to sustain market growth.
Angioplasty Balloons Market Report Segmentation:
By Product Type:
- Normal Balloons
- Cutting Balloons
- Drug Eluting Balloons
- Scoring Balloons
Based on the product type, the market is segmented into normal, cutting, drug eluting, and scoring balloons.
By Application:
- Coronary Angioplasty
- Peripheral Angioplasty
On the basis of application, the market has been categorized into coronary and peripheral angioplasty.
By Material:
- Nylon
- Polyurethane
- Silicone Urethane Co-Polymers
- Others
Based on the material, the market is divided into nylon, polyurethane, silicone urethane co-polymers, and others.
By End User:
- Hospitals
- Ambulatory Surgery Centers
- Others
On the basis of end user, the market has been divided into hospitals, ambulatory surgery centers, and others.
Regional Insights:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Based on the region, the market is segregated into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
Competitive Landscape with Key Players:
The competitive landscape of the angioplasty balloons market size has been studied in the report with the detailed profiles of the key players operating in the market.
Some of These Key Players Include:
- Abbott Laboratories
- Braun Melsungen AG
- BD (Becton, Dickinson, and Company)
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Endocor GmbH & Co. KG
- Johnson & Johnson
- Medtronic Inc.
- Terumo Corporation
Ask Analyst for Customized Report:
https://www.imarcgroup.com/request?type=report&id=2270&flag=C
Key Highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Website: imarcgroup.com
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
